MedPath

PHOENIX NEUROLOGICAL ASSOCIATES, LTD.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:4

Trial Phases

2 Phases

Phase 1:4
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (80.0%)
Phase 2
1 (20.0%)

Natalizumab in Inclusion Body Myositis (IBM)

Phase 1
Conditions
Inclusion Body Myositis (IBM)
Interventions
First Posted Date
2015-06-29
Last Posted Date
2017-02-09
Lead Sponsor
Phoenix Neurological Associates, LTD
Target Recruit Count
6
Registration Number
NCT02483845
Locations
🇺🇸

Phoenix Neurological Insitutute, Phoenix, Arizona, United States

Determining the Safety of L-serine in ALS

Phase 1
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
First Posted Date
2013-04-19
Last Posted Date
2015-07-30
Lead Sponsor
Phoenix Neurological Associates, LTD
Target Recruit Count
20
Registration Number
NCT01835782
Locations
🇺🇸

Phoenix Neurological Associates, Phoenix, Arizona, United States

🇺🇸

Forbes Norris MDA/ALS Research Center, San Francisco, California, United States

Dermatomyositis and Polymyositis Registry

Conditions
Dermatomyositis
Polymyositis
First Posted Date
2012-07-10
Last Posted Date
2015-11-06
Lead Sponsor
Phoenix Neurological Associates, LTD
Target Recruit Count
100
Registration Number
NCT01637064
Locations
🇺🇸

PNA Center for Neurological Research, Phoenix, Arizona, United States

🇺🇸

Ara Dikranian MD, San Diego, California, United States

🇺🇸

Neurology INC, Columbia, Missouri, United States

and more 2 locations

Safety Study of High Doses of Zinc in ALS Patients

Phase 1
Completed
Conditions
Amyotrophic Lateral Sclerosis
Interventions
First Posted Date
2010-12-13
Last Posted Date
2012-03-12
Lead Sponsor
Phoenix Neurological Associates, LTD
Target Recruit Count
10
Registration Number
NCT01259050
Locations
🇺🇸

Phoenix Neurological Associates, Phoenix, Arizona, United States

Memantine Therapy in Amyotrophic Lateral Sclerosis

Phase 2
Completed
Conditions
Amyotrophic Lateral Sclerosis
Interventions
First Posted Date
2009-11-25
Last Posted Date
2009-11-25
Lead Sponsor
Phoenix Neurological Associates, LTD
Target Recruit Count
20
Registration Number
NCT01020331
Locations
🇺🇸

Phoenix Neurological Associates, LTD, Phoenix, Arizona, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath